BlackRock, Inc. 13D and 13G filings for Aeglea BioTherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-06-09 3:20 pm Sale | 2022-05-31 | 13G | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | BlackRock, Inc. BLK | 117,707 4.800% | -2,232 (-1.86%) | Filing |
| 2022-06-09 3:20 pm Sale | 2022-05-31 | 13G | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | BlackRock, Inc. BLK | 117,707 4.800% | -725,964 (-86.05%) | Filing |
| 2022-02-03 4:41 pm Sale | 2021-12-31 | 13G | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | BlackRock, Inc. BLK | 119,939 6.100% | -9,660 (-7.45%) | Filing |